These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 30166557)

  • 1. Graves' orbitopathy occurs sex-independently in an autoimmune hyperthyroid mouse model.
    Schlüter A; Flögel U; Diaz-Cano S; Görtz GE; Stähr K; Oeverhaus M; Plöhn S; Mattheis S; Moeller LC; Lang S; Bechrakis NE; Banga JP; Eckstein A; Berchner-Pfannschmidt U
    Sci Rep; 2018 Aug; 8(1):13096. PubMed ID: 30166557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic immunization with mouse thyrotrophin hormone receptor plasmid breaks self-tolerance for a murine model of autoimmune thyroid disease and Graves' orbitopathy.
    Schlüter A; Horstmann M; Diaz-Cano S; Plöhn S; Stähr K; Mattheis S; Oeverhaus M; Lang S; Flögel U; Berchner-Pfannschmidt U; Eckstein A; Banga JP
    Clin Exp Immunol; 2018 Mar; 191(3):255-267. PubMed ID: 29058307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Early Wave of Macrophage Infiltration Intertwined with Antigen-Specific Proinflammatory T Cells and Browning of Adipose Tissue Characterizes the Onset of Orbital Inflammation in a Mouse Model of Graves' Orbitopathy.
    Philipp S; Horstmann M; Hose M; Daser A; Görtz GE; Jesenek C; Flögel U; Hansen W; Bechrakis N; Banga JPS; Eckstein A; Berchner-Pfannschmidt U
    Thyroid; 2022 Mar; 32(3):283-293. PubMed ID: 34779257
    [No Abstract]   [Full Text] [Related]  

  • 4. A Promising Mouse Model of Graves' Orbitopathy Induced by Adenovirus Expressing Thyrotropin Receptor A Subunit.
    Zhang M; Ding X; Wu LP; He MQ; Chen ZY; Shi BY; Wang Y
    Thyroid; 2021 Apr; 31(4):638-648. PubMed ID: 33076782
    [No Abstract]   [Full Text] [Related]  

  • 5. Cutting edge: retrobulbar inflammation, adipogenesis, and acute orbital congestion in a preclinical female mouse model of Graves' orbitopathy induced by thyrotropin receptor plasmid-in vivo electroporation.
    Moshkelgosha S; So PW; Deasy N; Diaz-Cano S; Banga JP
    Endocrinology; 2013 Sep; 154(9):3008-15. PubMed ID: 23900776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse model of Graves' orbitopathy induced by the immunization with TSHR A and IGF-1R α subunit gene.
    Wu R; Li N; Wang X; Wang S; Tan J; Wang R; Zheng W
    J Endocrinol Invest; 2024 Oct; 47(10):2507-2519. PubMed ID: 38662129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous induction of Graves' hyperthyroidism and Graves' ophthalmopathy by TSHR genetic immunization in BALB/c mice.
    Xia N; Ye X; Hu X; Song S; Xu H; Niu M; Wang H; Wang J
    PLoS One; 2017; 12(3):e0174260. PubMed ID: 28319174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fingolimod Improves the Outcome of Experimental Graves' Disease and Associated Orbitopathy by Modulating the Autoimmune Response to the Thyroid-Stimulating Hormone Receptor.
    Plöhn S; Hose M; Schlüter A; Michel L; Diaz-Cano S; Hendgen-Cotta UB; Banga JP; Bechrakis NE; Hansen W; Eckstein A; Berchner-Pfannschmidt U
    Thyroid; 2019 Sep; 29(9):1286-1301. PubMed ID: 31237525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulating gut microbiota in a mouse model of Graves' orbitopathy and its impact on induced disease.
    Moshkelgosha S; Verhasselt HL; Masetti G; Covelli D; Biscarini F; Horstmann M; Daser A; Westendorf AM; Jesenek C; Philipp S; Diaz-Cano S; Banga JP; Michael D; Plummer S; Marchesi JR; Eckstein A; Ludgate M; Berchner-Pfannschmidt U;
    Microbiome; 2021 Feb; 9(1):45. PubMed ID: 33593429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cre-loxP System-Based Mouse Model for Investigating Graves' Disease and Associated Orbitopathy.
    Bao Y; Kim D; Cho YH; Ku CR; Yoon JS; Lee EJ
    Thyroid; 2023 Nov; 33(11):1358-1367. PubMed ID: 37624749
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor.
    Nagayama Y; Kita-Furuyama M; Ando T; Nakao K; Mizuguchi H; Hayakawa T; Eguchi K; Niwa M
    J Immunol; 2002 Mar; 168(6):2789-94. PubMed ID: 11884447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota in experimental murine model of Graves' orbitopathy established in different environments may modulate clinical presentation of disease.
    Masetti G; Moshkelgosha S; Köhling HL; Covelli D; Banga JP; Berchner-Pfannschmidt U; Horstmann M; Diaz-Cano S; Goertz GE; Plummer S; Eckstein A; Ludgate M; Biscarini F; Marchesi JR;
    Microbiome; 2018 May; 6(1):97. PubMed ID: 29801507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling Graves' Orbitopathy in Experimental Graves' Disease.
    Banga JP; Moshkelgosha S; Berchner-Pfannschmidt U; Eckstein A
    Horm Metab Res; 2015 Sep; 47(10):797-803. PubMed ID: 26287396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linsitinib, an IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye disease.
    Gulbins A; Horstmann M; Daser A; Flögel U; Oeverhaus M; Bechrakis NE; Banga JP; Keitsch S; Wilker B; Krause G; Hammer GD; Spencer AG; Zeidan R; Eckstein A; Philipp S; Görtz GE
    Front Endocrinol (Lausanne); 2023; 14():1211473. PubMed ID: 37435490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reevaluating thyrotropin receptor-induced mouse models of graves' disease and ophthalmopathy.
    Baker G; Mazziotti G; von Ruhland C; Ludgate M
    Endocrinology; 2005 Feb; 146(2):835-44. PubMed ID: 15542454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role and molecular mechanism of gut microbiota in Graves' orbitopathy.
    Li Y; Luo B; Tong B; Xie Z; Cao J; Bai X; Peng Y; Wu Y; Wang W; Qi X
    J Endocrinol Invest; 2023 Feb; 46(2):305-317. PubMed ID: 35986869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graves' ophthalmopathy: eye muscle involvement in patients with diplopia.
    Nagy EV; Toth J; Kaldi I; Damjanovich J; Mezosi E; Lenkey A; Toth L; Szabo J; Karanyi Z; Leovey A
    Eur J Endocrinol; 2000 Jun; 142(6):591-7. PubMed ID: 10832104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current insights into animal models of Graves' disease and orbitopathy.
    Wiesweg B; Johnson KT; Eckstein AK; Berchner-Pfannschmidt U
    Horm Metab Res; 2013 Aug; 45(8):549-55. PubMed ID: 23613015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical models of Graves' disease and associated secondary complications.
    Moshkelgosha S; So PW; Diaz-Cano S; Banga JP
    Curr Pharm Des; 2015; 21(18):2414-21. PubMed ID: 25777757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orbital fibrosis in a mouse model of Graves' disease induced by genetic immunization of thyrotropin receptor cDNA.
    Zhao SX; Tsui S; Cheung A; Douglas RS; Smith TJ; Banga JP
    J Endocrinol; 2011 Sep; 210(3):369-77. PubMed ID: 21715431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.